Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127598271 | 12759827 | 1 | I | 20160601 | 20160919 | 20160919 | PER | US-ASTRAZENECA-2016SE60527 | ASTRAZENECA | 22.00 | YR | M | Y | 0.00000 | 20160919 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127598271 | 12759827 | 1 | PS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | U | 20639 | FILM-COATED TABLET | ||||||||
| 127598271 | 12759827 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 127598271 | 12759827 | 3 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 | |||||||||
| 127598271 | 12759827 | 4 | SS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | Oral | Y | U | 0 | TABLET | ||||||||
| 127598271 | 12759827 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Unknown | U | 0 | ||||||||||
| 127598271 | 12759827 | 6 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 127598271 | 12759827 | 7 | SS | REXULTI | BREXPIPRAZOLE | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 127598271 | 12759827 | 8 | SS | REXULTI | BREXPIPRAZOLE | 1 | Oral | 0 | 2 | MG | QD | ||||||||
| 127598271 | 12759827 | 9 | SS | REXULTI | BREXPIPRAZOLE | 1 | Oral | 0 | 3 | MG | QD | ||||||||
| 127598271 | 12759827 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127598271 | 12759827 | 11 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 127598271 | 12759827 | 12 | C | XANAX | ALPRAZOLAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127598271 | 12759827 | 1 | Agoraphobia |
| 127598271 | 12759827 | 2 | Anxiety |
| 127598271 | 12759827 | 3 | Agoraphobia |
| 127598271 | 12759827 | 4 | Anxiety |
| 127598271 | 12759827 | 7 | Anxiety |
| 127598271 | 12759827 | 8 | Anxiety |
| 127598271 | 12759827 | 9 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127598271 | 12759827 | Anxiety | |
| 127598271 | 12759827 | Drug ineffective | |
| 127598271 | 12759827 | Fatigue | |
| 127598271 | 12759827 | Gastrooesophageal reflux disease | |
| 127598271 | 12759827 | Headache | |
| 127598271 | 12759827 | Hunger | |
| 127598271 | 12759827 | Insulin resistance | |
| 127598271 | 12759827 | Malaise | |
| 127598271 | 12759827 | Movement disorder | |
| 127598271 | 12759827 | Nervous system disorder | |
| 127598271 | 12759827 | Off label use | |
| 127598271 | 12759827 | Paraesthesia | |
| 127598271 | 12759827 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127598271 | 12759827 | 2 | 2014 | 0 |